Спайдер торгуется выше уровня 156.00 после вчерашнего падения.
Европейские индексы на отрицательной территории.
Nikkei +1,22%
SPY (внутридневной график) снижение на премаркете. Сопротивление 157.00-156.50 Поддержка: 156.00 -155.50
Ожидаемая макроэкономическая статистика:
Beige Book to be released at 14:00
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: BPFH +13.7% (light volume), ASML +6.7%, MRTN +5.4% (light volume), ABMD +4.1%, MAT +2.4%, CPSS +2% (light volume).
Other news: CUR +14.2% (receives FDA approval to commence Phase II Stem Cell trial in Amytrophic Lateral Sclerosis), ACUR +9.3% (still checking), BCRX +7.5% (Bloomberg discusses increasing fears of Bird Flu as Herbel remedies are running out), ENDP +6.1% ( being attributed to FDA ruling on generic OxyContin), NAV +0.9% (receives EPA certification for 13-liter engine with SCR ), ARMH +0.5% (still checking for anything specific).
Analyst comments: LULU +0.2% (lululemon initiated with an Overweight at Barclays)
Gapping down:
In reaction to disappointing earnings/guidance: EOPN -26.2%, INWK -20.2%, CRUS -11.3%, BMI -8.1%, (light volume), TXT -6.3%, URI -4.8%, BAC -3.1%, LLTC -2.9%, BK -2.7%, (light volume), YHOO -1.8%, CSX -1.3%, INTC -1.2%, IBKR -0.4% (light volume).
Financial related names showing weakness: BCS -3.1%, DB -2.9%, UBS -2.6%, CS -2.1%, RBS -2.1%, HBC -2%, ING -1.6%, MS -1.4%.
Select metals/mining stocks trading lower: RIO -3.9%, BBL -3.7%, MT -3.2%, BHP -2.7%, AU -1.6%, GDX -0.5%.
Select oil/gas related names showing early weakness: SD -2.9%, TOT -2.5%, PTR -2.4%, RDS.A -2.2%, RIG -1.7%, BP -0.2%.
Other news: ZGNX -6% (still checking may be attributed to FDA Oxycotin reports), APL -2.4% (ticking lower, to acquire Eagle Ford midstream business for $1 bln from TEAK midstream; APL introduces 2014 EBITDA guidance of $450-500 mln and distributions of between $2.75-2.85/limited partner unit; announces public offering of common units), TS -2.2% (still checking), JCP -1.3% (J. C. Penney's private-label division mgr Nick Wooster has left the company, according to NYPost), AAPL -1.2% (tech names lower following INTC; also reports out suggest AAPL is targeted in China app investigation), KO -0.6% (trading lower following cautious Barron's mention).
Analyst comments: EQR -1.8% (downgraded to Mkt Perform from Outperform at Raymond James), DE -1.6% and CAT -1.6% (downgraded to Neutral from Outperform at Macquarie), ESS -0.9% (downgraded to Outperform from Strong Buy at Raymond James), AIV -0.6% (downgraded to Mkt Perform from Outperform at Raymond James)
Отчетыкомпаний:
Вчера после закрытия: BMI CATY CSX FLXS FULT IBKR INTC KID URI XWES YHOO
Сегодня перед открытием: ABT BAC BK BLX DGX DOV FCFS HBAN MAT NSLP PJC PNC STJ TXT WNS
Торговые идеи NYSE и NASDAQ:
CRUS –отчет, шорт ниже 19.00, выше 19.50 при закреплении акции над уровнем смотрим сетапы на лонг.
YHOO – отчет, лонг выше 23.75.
ALKS – новости FDA, смотрим акцию в лонг выше вчерашнего закрытия.
ENDP – новости FDA, возможен шорт от максимума постмаркета 37.50, либо ниже уровня 36.50 смотрим акцию на закрытие гэпа.
URI – шорт ниже 49.00 с потенциалом от доллар и выше.
YUM – шорт возможен на пробой уровня поддержки 66.00.
Другие интересные акции: CREE ALKSRHTCDEDISHACADPLDFTIAGCOPXPNFXHRSANV
Спайдер торгуется выше уровня 156.00 после вчерашнего падения.
Европейские индексы на отрицательной территории.
Nikkei -0,41%
SPY (внутридневной график) рост на премаркете. Сопротивление 156.50 Поддержка: 155.50
Ожидаемая макроэкономическая статистика:
Fed's Dudley speaks (8am)
March CPI (8:30am)- Headline consensus -0.1%, Core consensus +0.2%
March Housing Starts (8:30am)- Briefing.com consensus 930K, prior 930K
March Building Permits (8:30am)- Briefing.com consensus 945K, prior 946K
March Industrial Production (9:15am)- Briefing.com consensus +0.3%, prior +0.7%
March Capacity Utilization (9:15am)- Briefing.com consensus 78.4%, prior 78.3%
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: KO +3.1%, BRO +2.4%, PBY +1.8%, JNJ +1.4%, GS +0.6%.
M&A news: ANEN +9.9% (12.8% owner Vintage Capital Management submits proposal to acquire Co for $23/share, in 13G filing out last night), S +1.3% ( Bloomberg discusses that Sprint may receive higher bids following Dish Network offer, also reports out indicate Softbank is expected to stay in the race for Sprint following Dish Network offer; upgraded to Overweight from Neutral at JPMorgan), .
Select financial related names showing strength: RBS +3%, ING +2.8%, DB +2.8%, CS +1.9%, MS +1.7%, .
Metals/mining stocks trading higher: GFI +7.8%, AU +6.6%, GOLD +6.1%, KGC +4.8%, ABX +4.1%, AG +4%, HMY +3.2%, HL +3.1%, GDX +2.8%, SLV +2.8%, AUY +2.8%, EGO +2.6%, SLW +2.5%, GLD +2.3%, RIO +2.3% (reports Q1 attributable Iron Ore output of 48.3 MT), NEM +2%, MT +1.9%.
Other news: ASTI +12.1% (thinly traded, announces retail relationship with Fry's Electronics), MHR +4.2% (Provides 1Q2013 Co Wide Operational Update; On Apr 10, 2013, the co began drilling its first Utica Shale well on our Farley Pad), EGY +1.9% (provides update on drilling activities offshore), F +1.2% (trading higher after reports out yesterday suggested March sales outpaced TM in China), ASEI +1.1% (following late lift on Boston bombing news), FB +0.7% (conflicting reports out discuss potential FB talks over mobile software), COP +0.5% (China has an interest in buying stake in COP in developing Kazakhstan's oilfield, according to reports).
Analyst comments: HK +4.4% (initiated with a Outperform at Raymond James), MSFT +1.1% (assumed with an Overweight from Equal Weight at Morgan Stanley)
Gapping down:
In reaction to disappointing earnings/guidance: KEYN -6.8%, (light volume), ATI -5.3%, JOEZ -4.3%, NTGR -4.1%, HCA -3.3%, TGT -1.1%.
A few retailers pulling back following TGT guidance: KSS -0.9%, WMT -0.5%, COST -0.3%
Other news: LDK -18.8% (announces partial nonpayment for convertible notes), CLI -12.2% (confirms it intends to reduce quarterly dividend 33% to $0.30 from $0.45 per share), NBG -9.3% (still checking, Reuters details news that Cyprus has raised the amount Cyprus citizens can transfer between banks to EUR 3K from EUR 2K), SRPT -6.5% (announces FDA will consider accelerated approval for eteplirsen after further review of data on dystrophin and clinical outcomes, downgraded at Janney and Leerink), CCXI -4.3% ( commenced an underwritten public offering of $60 million of its common stock), ARMH -2.5% (still checking), DV -1.8% (disclosed that it received earlier this month a subpoena and more recently a Civil Investigative Demand).
Analyst comments: NKA -2.4% (downgraded to Sell from Neutral at Citigroup)
Отчеты компаний:
Вчера после закрытия: BRO ECTY JOEZ PBY ZOOM
Сегодня перед открытием: BLK CMA GS GWW JNJ KO MBWM NTRS TBOW USB
Торговые идеи NYSE и NASDAQ:
CLI– компания объявила о снижении дивидендов. Смотрим акцию на лонг выше уровня 24.50.
BRO– отчет компании. Акция находится у годового хая, смотрим на лонг выше 32.00, ниже этого уровня работаем от шорта.
NTGR– так же отчет. Смотрмм на уровень 29.00. Выше него смотрим акцию в лонг, ниже шорт.
SRPT– фармацевтическая компания. Движение на новостях FDA. Смотрим акцию в шорт ниже уровня 38.00, выше возможен лонг с потенциалом 1-2 доллара.
HCA– смотрим на лонг от уровня 34.00
WWW– еще одна отчетная компания. Смотрим в шорт ниже 44.00.
DDD– лонг выше 35.00, ниже 34.00 смотрим акцию в шорт.
Спайдер торгуется на премаркете ниже вчерашнего закрытия.
Европейские индексы на отрицательной территории.
Nikkei -1,55%
SPY (внутридневной график) боковое движение на премаркете. Сопротивление 158.25 Поддержка: 158.75
Ожидаемая макроэкономическая статистика:
Apr Empire Manuf 8:30am
Apr NAHB Housing Mkt Index 10am
Премаркет NYSE/NASDAQ:
Gapping up:
Gapping up
In reaction to strong earnings/guidance: C +1.8%.
M&A news: S +15.4% (DISH Network proposes merger with Sprint Nextel for $25.5 bln; S shareholders would receive $7.00 per share ($4.76 per share in cash and 0.05953 DISH shares per S share), LIFE +8.8% and TMO +1.8% (Thermo Fisher Scientific confirms agreement to acquire Life Technologies for $76.00 per share in cash), NFP +6.8% ( to be acquired by Madison Dearborn Partners for $25.35/share in cash ), ELN +0.6% (Royalty Pharma Announces Firm Offer to Acquire Elan; offer valued at up to $12.00 per share), .
Other news: ACOR +8.7% (announces positive AMPYRA (dalfampridine) Phase 2 data in people with post-stroke deficits), BCRX +3.2% (Bloomberg discusses that speculation of wider Bird Flu outbreak following a 4 yr old that got infected, according to reports), IOC +2% (ticking higher, InterOil announces statutory approvals), KT +1.2% (ticking higher, to drop bid for stake in VIVEF, according to reports).
Analyst comments: CMG +1.2% (upgraded to Buy from Neutral at UBS, upgraded to Outperform from Neutral at Wedbush), UA +0.2% (upgraded to Positive from Neutral at Susquehanna)
Gapping down:
In reaction to disappointing earnings/guidance: MTL -7.9%, CNQR -2.1%, (light volume).
Select financial related names showing weakness: NBG -11.8%, RBS -3.4%, DB -2.3% ( says its margins may improve, according to reports), BBVA -2.3%, SAN -2%, HBC -1.5%, CS -0.6%.
Metals/mining stocks trading lower: HMY -9.1% (downgraded to Sell from Neutral at Citigroup), SLV -9%, GOLD -8.3%, KGC -8.2%, IAG -8.1%, SLW -8%, PAAS -8%, GFI -7.4%, CDE -6.9% (reports steady first quarter production and reaffirms full-year production guidance ), IAG -6.4% ( definitive agreement with Government of Suriname approved by National Assembly),GG -6.7%, AEM -6.3%, AG -6.1%, NEM -5.1%, GLD -4.8%, MT -4.6%, RIO -4.4%, BHP -3.9%, BBL -3.4%, VALE -2.4%.
Oil/gas related names showing early weakness: APC -2.9%, TOT -2.6%, E -2.1%, STO -2%, BP -1.9%, SDRL -1.7%, .
Other news: STP -13.3%and SI -3% (still checking for anything specific), PCS -2.3% (MetroPCS amends agreement to combine with T-Mobile USA; Under the revised agreement, MetroPCS stockholders will continue to receive an immediate $1.5 bln aggregate cash payment), PCLN -1.2% (Barron's profiles cautious view on Priceline.com).
Analyst comments: NOR -9% (Noranda Aluminum downgraded to Neutral from Buy at Citigroup), FCX -5.1% (downgraded to Neutral from Buy at Citigroup), ACI -3.5% (downgraded to Neutral from Buy at Citigroup), ANR -3.3% (downgraded to Neutral from Buy at Citigroup), PWR -0.9% (downgraded to Outperform from Buy at Credit Agricole), INFY -0.8% (downgraded to Neutral from Buy at BofA/Merrill)
Отчеты компаний:
Сегодня перед открытием: ARTW BSPM C FRC LAYN MTB WBS
Other news: FST +15.5% (Forest Oil details accelerated Eagle Ford Shale drilling program), ASH +5.3% (JANA PARTNERS discloses 7.4% active stake in 13D filing), IOC +4.9% (ticking higher, is set to agree on Shell LNG partnership, according to reports), NFLX +2.9% (Netflix higher by ~2% in afer hours trading, CEO Reed Hastings said customers watched over 4 bln hours on Netflix over the past three months ), SHPG +1.1% (still checking), GLUU +1% (announced Lorne Abony has joined the company's Board of Directors as Chairman of the newly-created Strategy Committee), BBRY +0.7% (BlackBerry denies reports of weak sales and high returns for Z10 device, according to reports), LLY +0.5% (to lay off hundreds of sales reps, according to reports).
Analyst comments: RAD +3.8% (upgraded to Outperform from Mkt Perform at Raymond James ), HD +1.1% (upgraded to Buy from Hold at Jefferies), WSM +0.8% (added to Top Picks Live list at Citigroup), AMZN +0.2% (Hearing positive Credit Suisse comments; citiing structural and margin benefits from expanding fulfillment footprint )
Gapping down:
In reaction to disappointing earnings/guidance: INFY -16.6%, HRS -7.4%, XXIA -4.7%, JBHT -2.9%, WFC -1.4%, JPM -0.8%, .
Financial related names showing weakness: NBG -14.2% (ongoing speculation of additional bailout, Reuters discusses comments from officials that Cyprus is not planning to ask for more bailout money, following speculation overnight that it would), SAN -2.1%, BBVA -1.7%, MS -1.7%, BAC -1%, HBC -0.8% (downgraded to Hold from Buy at Liberum), GS -0.5%.
Metals/mining stocks trading lower: AG -2.7%, AUY -2.6%, HL -2.3%, GG -2.3%, ABX -1.3%, GLD -1.1%, SLV -1.1%, RIO -1%, BBL -1%, BHP -0.9%, NEM -0.9%, GOLD -0.6%, .
Other news: NVGN -18.8% (announces placement of stock to raise $2.5 mln), MNKD -6.8% (still checking), CTSH -4.7% (ticking lower following INFY results), WIT -3.8% (ticking lower following INFY results), CACC -2.5% (prices secondary offering by selling shareholders of 1.5 mln shares at $105.00 per share), DB -2.5% (still checking), DRTX -2.5% (Durata Therapeutics prices 7.15 mln share offering at $7.00 per share), JCP -2.1% (continued weakness, several stories out in the name), WERN -0.8% (following JBHT results), RTN -1.8% and GD -0.8% (following HRS guidance), TEVA -0.7% (weakness attributed to cautious comments on MadMoney), FB -0.7% (today is launch of FB home).
Analyst comments: MPW -3.1% (downgraded to Underperform from Neutral at BofA/Merrill), RUK -1.8% (downgraded to Hold from Buy at Jefferies), KO -0.9% (downgraded to Neutral from Buy at Davenport), KORS -0.6% (initiated with a Underperform at Credit Agricole).
Отчеты компаний:
Вчера после закрытия: CERE FFHL JRJC OZRK
Сегодня перед открытием: CAK CSUN GIGM JPM
Торговые идеи NYSE и NASDAQ:
WLT– смотрим акцию на шорт от уровня 26.00, если все же акция сможет закрепиться выше, то входим в лонг.
March Import/Export Prices (8:30am)- Prior 0.0%, +0.6%, respectively
Natural as Inventories (10:30am)
30-year Bond Auction (1pm)
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance/SSS: RAD +12.8%, ZUMZ +8%, BBBY +1.5%, COST +0.9% (light volume).
M&A news: LIFE 1.1% (continued M&A related speculation, WSJ discusses ongoing M&A speculation in LIFE as PE firms BX, KKR, and CG remain as possible buyout group).
Other news: ACAD +25.5% (announces expedited path to NDA Filing for Pimavanserin following meeting with FDA), AEZS +25.3% (presents encouraging updated data on its LHRH receptor-targeted Disorazol Z Cytotoxic Conjugates at AACR Meeting), AMRS +18.5% (describe breakthrough in development of anti-malarial drug precursor; Sanofi (SNY) utilizing Amyris engineered yeast strains to produce drug ingredient at scale), NMR +8.2% and TM +3.9% (following strength in overseas trading - Nikkei 2.0%), CTIC +5.3% (announces NICE issue draft guidance on PIXUVRI), PSTI +3% (United Therapeutics receives regulatory approval to commence Phase I study of Pluristem's PLX-PAD cells for pulmonary arterial hypertension), TI +2.4% (Telecom Italia Board considering to allow Hutchison Whampoa to purchase stake in TI, according to reports), ELN +1.5% (still checking), UL +1.1% (still checking), NBL +1.1% (trading higher following CEO comments, see company as doubling), IP +1% (reports out indicate Dan Loeb's Third Point LLC has increased its stake in International Paper).
Analyst comments: BYD +3% (upgraded to Overweight from Equal-Weight at Morgan Stanley), DGX +1.2% (upgraded to Buy from Neutral at Goldman), XRX +0.4% (Xerox initiated with an Overweight at Piper Jaffray), AMGN +0.3% ($125 from $106 at Lazard)
Gapping down:
In reaction to disappointing earnings/guidance/SSS: FTNT -17.7% (also downgraded by multiple analysts), APOG -7.5%, IART -7% (issues voluntary recall of certain products manufactured in its Anasco, Puerto Rico facility; expects revs lower by ~$8-11 mln in Q1, also downgraded by ,ultiple analysts), PIR -3.6%, YUM -3%, PFMT -1.1%, LTD -1%.
Select metals/mining stocks trading lower: MT -1.8%, GOLD -1.5%, AU -1.1% (downgraded to Hold from Buy at Societe Generale), BBL -0.7%, BHP -0.5%, SLV -0.3%, .
PC/tech names lower following disappointing IDC report: HPQ -5.5%, MSFT -3.9% (also downgraded at Goldman and Nomura), INTC -2.3%, TDC -0.8%
A few FTNT/security tech companies under pressure: FIRE -3.6%, PANW -2.8%, CHKP -1.6%
Other news: AFFY -17% (disclsoed that AFFY and Takeda Pharmaceutical entered into the Fourth Amendment to the February 13, 2006 and June 27, 2006 collaboration andlLicense agreements), SSH -8.2% (has commenced underwritten public offering of common stock pursuant to effective shelf registration previously filed with the SEC), SGYP -5.2% (prices 16.375 mln shares of common stock for gross proceeds of ~$90 mln ), INFI -4% (announces pricing of secondary offering of common stock by existing shareholders Beacon Company and Rosebay Medical Company ), FSC -3.8% (commences public offering of 13.5 mln shares of common stock), ROYL -2.4% (modestly pulling back), PKX -1.6% (still checking), RLGY -0.6% (prices 35 mln share offering by certain funds affiliated with Apollo Global Management (APO) at $44.00 per share ).
Отчеты компаний:
Вчера после закрытия: RT RELL APOG CHC
Сегодня перед открытием: NTIC CBSH IGTE PIR RAD LEDS
Торговые идеи NYSE и NASDAQ:
FTNT– очень сильное падение на постмаркете и премаркете, реакция на Guidance. Ключевые уровни 18.00 и 19.00, работаем от них.
BBBY– отчет и гайденс на текущий год. При закрепелнии 67.00 смотрим акцию в лонг, ниже 66.00 – шорт.
YUM– опубликовали результаты по продажам на фоне птичьего гриппа в Китае. Снижение продаж примерно на 13%, смотрим акцию в шорт ниже 64.00, выше 65.50 – лонг.
ACAD– опубликован новый документ FDA по результатам 3его этапа испытаний препарата компании. Очень сильный рост на премаркете, ниже 12.00 смотрим сетапы в шорт с потенциалом от 50 центов до доллара.
Спайдер торгуется на премаркете около уровня 157.00
Европейские индексы на положительной территории.
Nikkei +0,73 %
SPY (внутридневной график) боковое движение на премаркете. Сопротивление 157.25 Поддержка: 157.00, 156.25
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: ADTN +10.7% (light volume), ACTS +9.8%, PSMT +3.5% (also reports March net warehouse club sales +11.5%; comparable net warehouse club sales +7.9%).
Financial related names showing strength: CS +3.4%, BBVA +3.4%, BCS +3.1%, RBS +3%, ING +2.7%, UBS +2.3%, SAN +2.2%, DB +2%.
Other news: BCRX +11.4% (light volume, Bloomberg discusses that China Bird Flu outbreak may came from two other viruses, according to reports ), MNKD +5.9% (continued strength), WOR +4.3% (acquires Palmer Mfg. & Tank business ), STP +3.2% (may sell some assets and bring in strategic investor, according to reports), YHOO +1.6% (Yahoo! and Apple (AAPL) are in discussions for deeper IoS partnership, according to reports), FB +1.5% (AllThingsD discusses FB's data targeting efforts, according to reports), SRPT +1.1% (following 5 point jump after GSK's data for drisapersen did not appear as strong as that of Sarepta's eteplirsen), JNPR +1.0% (Belgacom selects Juniper Networks 100GE Routing Solution).
Analyst comments: PSUN +6.7% (upgraded to Overweight from Neutral at Piper Jaffray), IBM +1.3% (upgraded to Buy from Neutral at UBS), AEO +1.1% (upgraded to Overweight from Neutral at Piper Jaffray, STWD +0.9% (upgraded to Buy from Neutral at BofA/Merrill ), CYS +0.5% (upgraded to Outperform from Mkt Perform at Keefe Bruyette), SI +0.3% (upgraded to Neutral from Underperform at Exane BNP Paribas)
Gapping down:
In reaction to disappointing earnings/guidance: HMA -12.6%, (downgraded to Hold from Buy at Deutsche Bank), TITN -11.5%, SEAC -9.7%, RLGY -7.6%, (also announced an underwritten public offering of 35 million shares of its common stock by certain funds affiliated with Apollo Global Management), GRA -5.3% (ticking lower), FDO -3.8%, JKS -2.6%, FAST -1.7% (light volume), DGIT -0.7%.
M&A news: LIFE -0.3% (Thermo Fisher has made an offer for LIFE for more than $65/share, according to reports).
Select HMA peers under pressure: THC -6.9% (downgraded to Hold from Buy at Deutsche Bank), CYH -3.9% (downgraded to Hold from Buy at Deutsche Bank), UHS -2.0%.
Select solar names modestly pulling back (JKS reported earnings and FSLR cautious analyst comments): FSLR -2.9% (modestly pulling back, multiple analysts are out this morning suggesting the upside move on yesterday's guidance is overdone), TSL -2.5%, SPWR -2.3%, YGE -1.8%, WFR -1.3%.
Select metals/mining related names showing early weakness: HL -1.5%, ABX -0.8%, BHP -0.7%, NEM -0.6%, GG -0.5%, GLD -0.5%, SLW -0.5% .
Other news: SGYP -11.2% (announces public offering of $90 mln of common stock), RSO -3.5% (announces follow-on offering of 16.25 mln shares of its common stock), HBIO -3% (announces postponement of the IPO for Harvard Apparatus Regenerative Technology, Inc.), INFI -2.4% (announced an underwritten public offering of its common stock by existing stockholders), SHPG -0.9% (still checking).
Отчеты компаний:
Вчера после закрытия: CCIH PSMT SEAC
Сегодня перед открытием: ATNY FAST FDO JKS KMX MSM STZ TITN
Торговые идеи NYSE и NASDAQ:
RLGY– плохой guidance на первый квартал 2013, дополнительное размещение 35млн акций среди акционеров. Смотрим акцию в лонг выше 42.00, либо на отбой от уровня 40.00. Шорт возможен на пробой минимума постмаркета 41.00.
ADTN– отчет чуть лучше ожиданий, но прибыль не растет. Выше 20.00 смотрим акцию в лонг, ниже – шорт. В 9-30 Conference Call.
HMA – так называемый Grow Stock, плохой гайденс на следующий квартал, покупаем от поддержки 11.00. Связанная компания: THC (госпитали).
FDO– отчет примерно на уровне ожиданий, но плохой гайденс на FY13. Смотрим акцию в шорт ниже уровней премаркета, лонг возможен выше уровня 58.00. Связанные тикеры: DLTR, DG
ARO– компания попала в список Sell Goldman Sachs, смотрим акцию в лонг от 12.00, если будет падение.
Спайдер торгуется на премаркете около уровня сопротивления 155.50.
Европейские индексы на положительной территории.
Nikkei +2,8 %
SPY (внутридневной график) рост на премаркете. Сопротивление 155.50-156.00 Поддержка: 154.75 – 154.00
Ожидаемая макроэкономическая статистика:
Нет значимых событий
Премаркет NYSE/NASDAQ:
Gappingup
In reaction to strong earnings/guidance: AZZ +0.4%.
M&A news: LUFK +37.3% (Lufkin Industries confirms it will be acquired by GE for $3.3 bln or $88.50/share in cash).
Select oil/gas related names showing strength boosted by LUFK news: WFT +2.2%, NBR +2%, OXY +1.1%.
Other news: BCRX +23.5% and NVAX +5% (more reports of China bird flu deaths), BSDM +7.8% (announces exclusive multi-million dollar distribution agreement with Terumo Europe NV), TSL +6.4% (Trina Solar Chairman says company plans to return to profit in the second half of 2013, according to reports), AMRN +3.6% (announces new clinical data showing significant reductions in Apolipoprotein C-III levels in MARINE and ANCHOR Studies of Vascepa; Amarin's MARINE and ANCHOR trials, the 4 gram dose of Vascepa achieved reductions), CLF +3.5% (Barron's profiles positive view on Cliffs Natural Resources (CLF); mentions that company could become takeover target of valuation falls), STZ +3.3% (Constellation Brands has reached an agreement with DoJ; Parties request extension of the present stay of proceedings until April 23, 2013 to finalize proposed consent judgment), CYMI +2.3% (Cymer: U.S. Department of Justice clears ASML acquisition of Cymer), SRPT +1.9% (still checking), BUD +1.6% (Constellation Brands has reached an agreement with DoJ; Parties request extension of the present stay of proceedings until April 23, 2013 to finalize proposed consent judgment), AAPL +1.2% (still checking for anything specific), JPM +0.4% ( Dealbook discusss that JPM is working to prevent spilt of Chairman and CEO positions).
Analyst comments: RDN +2.5% (upgraded to Outperform from Neutral at Macquarie),-F and si WLL +2.1% (upgraded to Overweight from Neutral at JP Morgan), JNPR +2% (hearing upgraded to Buy from Hold at Argus), PERI +1.8% (initiated with a Buy at Needham based on strong product pipeline & valuation; tgt $14), NVS +0.9% (upgraded to Neutral from Underperform at BofA/Merril )
Gapping down
M&A news: OMPI -5.6% (Merz Pharma Group Withdraws Proposal to Acquire OMPI).
Select financial related names showing weakness: ING -1.4%, CS -1.3%, UBS -1.2%, HBC -0.6%.
Other news: CEDC -25% (won creditor approval of proposed restructuring plan), NBG -16.7% (following WSJ.com report suggesting Greek merger stopped), DCTH -6.2% (receives notification of PDUFA date extension), BYI -5% (still checking), YUM -0.7% (following news of new Chinese bird flu outbreak).
Analyst comments: JNJ -0.7% (downgraded to Neutral from Overweight at JP Morgan)
Торговые идеи NYSEи NASDAQ:
BBY – акция показывала силу в течении 2х дней. На премаркете торгуется у уровня сопротивления. Выше 25.50 смотрим акцию в лонг.
STZ – малообъемный премаркет, смотрим акцию в лонг выше 49.50.
BCRX – рост на новостях об эпидемии птичьего гриппа в Китае. Выше 2.00 смотрим акцию в лонг, ниже – шорт с потенциалом 25 центов.
YUM – шорт ниже 66.00 с потенциалом доллар и выше. Акция может быть волатильна на новостях об эпидемии в Китае.
Спайдер торгуется на премаркете ниже ключевого уровня 155.00.
Европейские индексы на отрицательной территории.
Nikkei +1,6 %, Shanghai - закрыт.
SPY (внутридневной график) падение на премаркете. Сопротивление 155.25. Поддержка: 154.75
Ожидаемая макроэкономическая статистика:
Fed's Yellen speaks (5pm)
March Nonfarm Payrolls (8:30am)- Briefing.com consensus 192K
March Nonfarm Private Payrolls (8:30am)- Briefing.com consensus 210K
March Unemployment Rate (8:30am)- Briefing.com consensus 7.7%
March Hourly Earnings (8:30am)- Briefing.com consensus +0.2%
March Average Workweek (8:30am)- Briefing.com consensus 34.5
February Trade Balance (8:30am)- Briefing.com consensus -$44.7 bln
February Consumer Credit (8:30am)- Briefing.com consensus $14 bln
Премаркет NYSE/NASDAQ:
Gapping up
In reaction to strong earnings/guidance: WDFC +7.5%, XRTX +1.9%, HBI +1.8%.
Other news: XIDE +24.1% (modestly rebounding, confirmed it has retained financial advisor; sees Q4 free cash flow of ~$50 mln vs prior guidance of $30 mln), NIHD +7.9% (announces sale of Nextel Peru to Entel for $400 mln), MAKO +4.8% (MAKO Surgical secures court-ordered permanent injunction against Blue Belt Technologies), VLO +3.8% (Board approves spin-off of CST Brand), APP +2.9% ( closes private offering of $206 mln principal amount of its 13% senior secured notes due 2020; enters into a new $35 mln five-year asset-backed revolving credit facility with Capital One Bank), ATRS +1.7% (announces notice of allowance for new patent on VIBEX QuickShot Device).
Analyst comments: BBG +1.8% (ticking higher, upgraded to Buy from Neutral at Goldman), CELG +0.9% (upgraded to Buy from Hold at Deutsche Bank), MBT +0.3% (upgraded to Overweight from Neutral at JP Morgan)
Gapping down
In reaction to disappointing earnings/guidance: FFIV -17.1% (also multiple analyst downgrades and tgt cuts), RDWR -17%.
Financial related names showing weakness: NBG -9%, BCS -2.6%, ING -2.6%, HBC -1.5%, C -1.2%, DB -1.1%, BAC -0.9%, .
Select oil/gas related names showing early weakness: PTR -1.9%, RIG -1.4%, E -1.2%, SDRL -0.8%, RDS.A -0.8% (Royal Dutch Shell to sign Russian Artic drilling deal, according to reports), BP -0.7%, TOT -0.6%, STO -0.5%.
Several FFIV/RDWR related names are under pressure: JNPR -5.6%, CTXS -3.6%, CSCO -3.3%, VMW -2.5%, RAX -2.3%, CRM -1.9%, XLNX -1%,
Other news: RIGL -29.6% (AstraZeneca reports top-line results from OSKIRA-1 Phase 3 study of Fostamatinib in Rheumatoid Arthritis, Rigel Pharma downgraded to Market Perform from Outperform at BMO Capital Mkts), SABA -12% (announced anticipated delisting from NASDAQ global select market; disclosed SEC investigation), ETP -3.5% (announces 12 mln common unit offering), SAP -2.5% and DEO -1.7% (still checking), BDN -1.1% (announces offering of 10 mln common shares), UL -0.9% (still checking), LVS -0.5% (Las Vegas Sands CEO Sheldon Adelson says Richard Suen did not help co get Macau license, according to reports).
Analyst comments: KMB -0.6% (downgraded to Underperform from Market Perform at BMO Capital)
Торговые идеи NYSEи NASDAQ:
NIHD – компания анонсировала продажу подразделение Nextel Peru за 400 млн долларов. Акции слабее рынка. Ключевые уровни – 4.50 и 5.00. Работаем исходя из цены открытия.
VLO – совет директоров одобрил Spin off CST Brands. Смотрим акцию в лонг выше 43.00. Ориентируемся на уровень 43.50.
CSCO – компания торгуется на премаркете ниже вчерашнего закрытия. Причина – реакция на conference call F5 Networks (FFIV). Выше 20.50 смотрим акцию в лонг с потенциалом в 50 центов. Другие компании отреагировавшие аналогично: JNPR(лонг выше 17.25, шорт ниже 17.00), CRM, CTXS, VMW.
ETP– дополнительное размещение 12 млн. акций. Ниже 48.00 смотрим акцию на шорт, выше 48.50 можно искать точку входа на лонг.
In reaction to strong earnings/guidance: GBX +3.2%.
Financial related names showing strength: ING +5% (upgraded to Outperform from Neutral at Exane BNP Paribas ), RBS +4.3%, ING +3.6%, BBVA +2%, SAN +1.9%, DB +1.8% (derivatives portfolio is being probed by German regulators, according to reports ), BCS +1.3%, BAC +0.8%, JPM +0.7%, C +0.7%, HBC +0.3%.
Select metals/mining stocks ticking higher: VALE +2.1%, MT +1.8%, RIO +1.5% (Some RIO mines may be purchased by Coal India, according to reports), BBL +1.3%, BHP +0.9%.
Select Japan related names ticking higher after the BOJ has announced a open-ended bond purchase plan: SMFG +5.2%, NMR +5.1%, TM +3.5%, MTU +3.4%, HMC +3%.
A few telcom names are higher: TEF +2.4%, TI +2.1%, FTE +1.1%
Other news: NAVB +6.7% (Navidea Biopharmaceuticals reports positive top-line results from interim analysis of Lymphoseek Phase 3 clinical trial in head and neck cancer), RDY +3.2% (light volume, Dr. Reddy's launches Zoledronic Acid Injection), FB +0.6% (ahead of expected Android launch), .
Analyst comments: NKA +6.9% (light volume, upgraded to Outperform from Market Perform at Wells Fargo, upgraded to Equal Weight from Underweight at Barclays), PT +6.3% (added to Conviction Buy at Goldman), PANL +3.1% (upgraded to Buy at Needham), FNSR +3.1% (upgraded to Buy from Neutral at Lazard), SRPT +2.8% (initiated with Outperform at Baird), PNRA +2.1% (added to Conviction Buy list at Goldman), TMH +1.8% (added to Conviction Buy list and upgraded from Neutral at Goldman ), BRO +1.5% (ticking higher, upgraded to Neutral from Sell at Goldman), EAT +0.8% (upgraded to Buy from Neutral at Goldman), AAPL +0.4% (initiated with a Buy at Lazard)
Gapping down
In reaction to disappointing earnings/guidance: CPWR -2.7%, MIND -2.5%, LULU -1.5%.
A few European drug names are lower: NVS -1.3%, AZN -1.1%
Other news: MACK -7.4% (announces top-line results from a single arm Phase 2 advanced lung cancer study in patients with resistance to an anti-EGFR tyrosine kinase inhibitor -- one cohort of a Phase 2 non-small cell lung cancer study did not meet its primary endpoint), LSE -2.4% (announced the commencement of a public offering of 6,500,000 shares of its common stock), STM -2.2% and ARMH -1.9% (still checking), CCL -1.9% (continued weakness on Triumph news), DEO -1.4% (still checking), RDS.A -0.6% (Royal Dutch Shell Geelong Australia refinery is now for sale, according to reports ).
Analyst comments: LCC -1.8% (downgraded to Neutral from Buy at BofA/Merrill), ARUN -1.8% (downgraded to Neutral from Buy at UBS), AVA -1% (ticking lower, downgraded to Neutral from Buy at UBS), MSFT -0.6% (downgraded to Neutral from Buy at BofA/Merrill)
Торговые идеи NYSEи NASDAQ:
CPWR – компания понизила прогноз по EPS и выручке на 4 квартал. Лонг выше 11.75, ниже 11.50 смотрим акцию в шорт с потенциалом от 25 до 50 центов.
CCL – компания из индекса SP500. На премаркете небольшой гэп вниз, ниже 32.75 смотрим акцию в шорт.
GBX – смешанный отчет, ожидают FY13 таким же как FY12. Премаркет малоактивный, но на открытии возможна хорошая волатильность. Ключевой уровень – вчерашний максимум 23.00 и минимум 21.50.
Спайдер торгуется на премаркете с незначительным понижением.
Европейские индексы на отрицательной территории.
Nikkei +3.0 %, Shanghai около нулевой отметки.
SPY (внутридневной график) рост на премаркете. Сопротивление 157.00. Поддержка: 156.60
Ожидаемая макроэкономическая статистика:
MBA Mortgage Index (7am)- Prior +7.7%
March ADP Employment Change (8:15am)- Briefing.com consensus 197K
March ISM Services (10am)- Briefing.com consensus 55.5, February 56.0
Petroleum Inventories (10:30am)
Премаркет NYSE/NASDAQ:
Gapping up
In reaction to strong earnings/guidance: CALL +15.1%, MON +1.9%, GIII +1.7%.
M&A news: OMPI +11.5% (Obagi Medical and Valeant Pharmaceuticals agree on an increased offer price of $24.00 per share in cash).
Other news: ZNGA +10.7% (announces ZyngaPlusPoker and ZyngaPlusCasino launching for UK players; co's first real money games), NVAX +8.5% (reports positive top-line results from Phase 2 clinical trial of RSV vaccine candidate in women of childbearing age), MHR +7.6% (Penn Virginia enters into a definitive agreement with Magnum Hunter Resources (MHR) to acquire producing properties and undeveloped leasehold interests in the Eagle Ford Shale play for ~ $400 mln), GLUU +7.3% (higher with ZNGA), NFX +7.2% ( announces 'significant' discovery offshore Malaysia, provides update on process to explore strategic alternatives for international businesses), ZOLT +5.9% ( announces review of its strategic alternatives), BUD +1.7% and NVO +1.6% (still checking), FB +1.1% (SEC says social media OK for company announcements if investors are alerted), CSCO +0.2% (announces intent to acquire Ubiquisys, a provider of 3G and long-term evolution small cell technology for approx $310 mln in cash and retention-based incentives).
Analyst comments: ALXA +7.1% (upgraded to Overweight from Neutral at Piper Jaffray), SIX +0.9% (added to Conviction Buy List at Goldman), NEE +0.9% ( added to Conviction Buy List at Goldman), NKE +0.8% (tgt to $67 from $56 at HSBC), CMG +0.7% (upgraded to Mkt Perform from Underperform at Raymond James)
Gapping down
In reaction to disappointing earnings/guidance: GPN -6.4%, ATML -3% (also appoints Steve Skaggs as interim Chief Financial Officer), CAG -2.1%
A few financial related names showing weakness: NBG -5.5%, ING -1.8%, SAN -1.3%, RBS -1.3%, BBVA -1.1%.
Select metals/mining stocks trading lower: GFI -2.9% (downgraded to Neutral from Outperform at Credit Suisse), HMY -2%, BHP -1.1%, BBL -0.8%, MT -0.7%, AU -0.7% (AngloGold downgraded to Neutral from Outperform at Credit Suisse).
A few telecom names trading lower: VOD -3.5% (Verizon discloses it is a willing purchaser of the 45% stake Vodafone holds in Verizon, but does not have any intention to merger with or make an offer for Vodafone), FTE -2.9%, PT -2.2%
Other news: TTM -4.8% (light volume, still checking), SEP -3.7% (commenced an underwritten public offering of 4,500,000 of its common units representing limited partner interests), ARCC -2.8% (announces public offering of 16.65 mln shares of common stock), TSLA -2.6% (announces new finance product in partnership with Wells Fargo (WFC) and US Bank ), LCC -0.9% (reports record March Load Factor of 86.1%, up 1.5 points YoY; PRASM results are lower than previous guidance), CHFN -0.4% (announces results of Stock Offering, Stockholder Vote and Member Vote).
Analyst comments: ADT -1.7% (downgraded to Underweight from Equal-Weight at Morgan Stanley),CRL -2.6% (ticking lower, downgraded to Sell from Neutral at Citigroup), CNS -2.1% (downgraded to Underperform from Buy at BofA), LM -1.4%
Торговые идеи NYSEи NASDAQ:
NFX– компания сообщила об открытии месторождения газа в Малайзии. Технически – очень слабая акция. Смотрим в шорт от уровней предыдущего пика – 24.00-24.20
TSLA – производитель автомобилей сообщил о новом партнерском соглашении (лизинг и кредитные программы) с Wells Fargo. Акция торгуется достаточно высоко, при закреплении выше 44.00 смотрим акцию в лонг.
CAG – отчет хуже ожидание аналитиков по EPS и выручке, подтверждение прогноза по EPS на FY13. Выше 34.00 смотрим акцию в лонг, потенциал движения 25-50 центов.
Оставить комментарий
